Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronary Heart Disease Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07641582
What this trial is testing

Prediction of Atrial Fibrillation Using Polygenic Risk Score

Who this might be right for
Atrial Fibrillation (AF)
Seoul St. Mary's Hospital 800
Not applicableActive Not RecruitingNCT02701283
What this trial is testing

Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

Who this might be right for
Aortic Valve Stenosis
Medtronic Cardiovascular 2,223
Not applicableStudy completedNCT02385682
What this trial is testing

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction

Who this might be right for
Long-term Major Cardiovascular EventsMyocardial InfarctionPercutaneous Coronary Intervention
Kiyuk Chang 4,748
Not applicableStudy completedNCT00142701
What this trial is testing

Enhancing Support for Women at Risk for Heart Disease

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCoronary Disease+2 more
Oregon Research Institute
Large-scale testing (Phase 3)Study completedNCT01323153
What this trial is testing

Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 300
Not applicableStudy completedNCT00885612
What this trial is testing

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Who this might be right for
Breast Cancer
AstraZeneca 1,114
Not applicableStudy completedNCT05387902
What this trial is testing

Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry

Who this might be right for
Coronary Artery Disease
Robert Jan van Geuns 25
Not applicableStudy completedNCT05710302
What this trial is testing

Prospective Validation of the Emergency Heart Failure Mortality Risk Grade (EHMRG) Score in Patients With Acute Heart Failure in the Emergency Department

Who this might be right for
Heart FailureHeart DiseasesAcute Heart Failure
Marmara University Pendik Training and Research Hospital 239
Not applicableStudy completedNCT05752188
What this trial is testing

Prognostic Value of Cardiovascular Risk of sST2 and Troponin I-hs in Patients With Acute Chest Pain

Who this might be right for
Acute Chest PainAcute Coronary Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT03153033
What this trial is testing

Fatigue Induced by Overground Wheelchair Propulsion in Persons With a Spinal Cord Injury: Upper Limb Saving or Straining?

Who this might be right for
Spinal Cord InjuriesFatigue; Muscle, Heart
Swiss Paraplegic Research, Nottwil 50
Not applicableStudy completedNCT00655447
What this trial is testing

Examining the Long-Term Risks of Oophorectomy

Who this might be right for
Coronary Heart DiseaseStrokeBreast Cancer+4 more
Parker, William H., M.D. 32,175
Not applicableLooking for participantsNCT06383208
What this trial is testing

Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics

Who this might be right for
Chronic Kidney DiseasesCoronary Heart DiseaseLipid Metabolism Disorders
China-Japan Friendship Hospital 470
Large-scale testing (Phase 3)Looking for participantsNCT07582835
What this trial is testing

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino 355
Not applicableStudy completedNCT02955238
What this trial is testing

Latinos Understanding the Need for Adherence

Who this might be right for
AtherosclerosisHigh Blood PressureType 2 Diabetes Mellitus+2 more
San Diego State University 587
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Post-approval studies (Phase 4)Looking for participantsNCT07322237
What this trial is testing

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Who this might be right for
Cirrhotic CardiomyopathyEmpagliflozinCardiometabolic Risk Factors+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 400
Not applicableStudy completedNCT00544739
What this trial is testing

Premature Coronary Artery Disease in Women - Risk Factors and Prognosis

Who this might be right for
Coronary Atherosclerosis
National Institute of Cardiology, Warsaw, Poland 670
Not applicableStudy completedNCT04124237
What this trial is testing

Long Term Monitoring for Risk of Sudden Death

Who this might be right for
Inherited Cardiac ArrhythmiasLong QT SyndromeArrhythmogenic Right Ventricular Cardiomyopathy+2 more
University of British Columbia 1,051
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Testing effectiveness (Phase 2)Looking for participantsNCT06922994
What this trial is testing

Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

Who this might be right for
Arrhythmogenic Cardiomyopathy
Centro Cardiologico Monzino 102
Next Page